ロード中...
ERK and p38MAPK combine to improve survival in patients with BRAF mutant colorectal cancer
BACKGROUND: In colorectal cancer (CRC), BRAF mutations influence tumour progression. In mismatch repair-deficient (dMMR) tumours, BRAF mutations are associated with a good prognosis, whereas in MMR-competent tumours, they are detrimental. The differential expression of the downstream MAPK pathway me...
保存先:
| 出版年: | Br J Cancer |
|---|---|
| 主要な著者: | , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Nature Publishing Group UK
2018
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6070918/ https://ncbi.nlm.nih.gov/pubmed/29988110 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41416-018-0174-y |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|